EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?

L Fernández, A C Duarte, A Rodríguez, P García

Beneficial Microbes · 12.04.2021 · 12 (2) · 107-120

DOI: 10.3920/bm2020.0132 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Beneficial Microbes, erschienen am 12.04.2021. Verfasst von L Fernández und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, 33300 Villaviciosa, Asturias, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the context of the global antibiotic resistance crisis, bacteriophages are increasingly becoming promising antimicrobial agents against multi-resistant bacteria. Indeed, a huge effort is being made to bring phage-derived products to the market, a process that will also require revising the current regulations in order to facilitate their approval. However, despite the evidence supporting the safety of phages for humans, the general public would still be reluctant to use ‘viruses’ for therapeutic purposes. In this scenario, we consider that it is important to discuss the role of these microorganisms in the equilibrium of the microbiota and how this relates to human health. To do that, this review starts by examining the role of phages as key players in bacterial communities (including those that naturally inhabit the human body), modulating the species composition and contributing to maintain a ‘healthy’ status quo . Additionally, in specific situations, e.g. an infectious disease, bacteriophages can be used as target-specific antimicrobials against pathogenic bacteria (phage therapy), while being harmless to the desirable microbiota. Apart from that, incipient research shows the potential application of these viruses to treat diseases caused by bacterial dysbiosis. This latter application would be comparable to the use of probiotics or prebiotics, since bacteriophages can indirectly improve the growth of beneficial bacteria in the gastrointestinal tract by removing undesirable competitors. On the other hand, possible adverse effects do not appear to be an impediment to promote phage therapy. Nonetheless, it is important to remember their potentially negative impact, mainly concerning their immunogenicity or their potential spread of virulence and antibiotic resistance genes, especially by temperate phages. Overall, we believe that phages should be largely considered beneficial microbes, although it is paramount not to overlook their potential risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAnimalsBacteriaBacterial InfectionsBacteriophagesDysbiosisGastrointestinal TractHumansPhage Therapy

Stichwörter der Autor:innen

dysbiosismicrobiotaphagephage therapyvirome

Autor:innen und Institutionen

  • Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, 33300 Villaviciosa, Asturias, Spain.
  • DairySafe Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Av. del Hospital Universitario s/n, 33011 Oviedo, Spain.

Zitieren

APA

Fernández, L., Duarte, A. C., Rodríguez, A., & García, P. (2021). The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?. Beneficial Microbes, 12(2), 107-120. https://doi.org/10.3920/bm2020.0132

Vancouver

Fernández L, Duarte AC, Rodríguez A, García P. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?. Beneficial Microbes. 2021;12(2):107-120. doi:10.3920/bm2020.0132

BibTeX
@article{Fernndez2021,
  author = {Fernández, L and Duarte, A C and Rodríguez, A and García, P},
  title = {The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?},
  journal = {Beneficial Microbes},
  year = {2021},
  volume = {12},
  number = {2},
  pages = {107--120},
  doi = {10.3920/bm2020.0132}
}
Kostenlos starten →